Effects of Age and Ethnicity on the Benefits and Risks of Low- versus Standard-dose Alteplase in Acute Ischemic Stroke Patients: The Enchanted Trial

被引：0
|
作者：
Wang, Xia
Robinson, Thompson
Arima, Hisatomi.
Broderick, Joseph
Demchuk, Andrew
Donnan, Geoffrey
Kim, Jong
Lavados, Pablo
Lee, Tsong Hai
Lindley, Richard
Martins, Sheila
Pandian, Jeyaraj
Chalmers, John
Anderson, Craig
机构：
来源：
STROKE | 2017年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
ATMP25
引用
收藏
页数：2
相关论文
共 50 条
  • [21] To treat acute ischemic stroke with standard-dose or low-dose alteplase? An individualized decision making tool
    Wang, Xia
    Li, Qiang
    Carcel, Cheryl
    Delcourt, Candice
    Anderson, Craig
    Woodward, Mark
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 30 - 30
  • [22] Low-dose versus standard-dose alteplase for intravenous thrombolysis in patients with acute ischemic stroke in Iran: Results from the safe implementation of treatments in stroke registry
    Sadeghi-Hokmabadi, Elyar
    Ghoreishi, Abdoreza
    Rikhtegar, Reza
    Sariaslani, Payam
    Rafie, Shahram
    Vakilian, Alireza
    Sharifipour, Ehsan
    Mehrpour, Masoud
    Saadatnia, Mohammad
    Mirza-Aghazadeh-Attari, Mohammad
    Farhoudi, Mehdi
    CURRENT JOURNAL OF NEUROLOGY, 2021, 20 (04): : 208 - 213
  • [23] Low-dose versus standard-dose intravenous alteplase in bridging therapy among acute ischemic stroke: Experience from a stroke centre in Vietnam
    Phan, H.
    Mai, T. D.
    Dao, Viet P. V.
    Vu, L. D.
    INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (1_SUPPL) : 24 - 24
  • [24] Low-dose vs. standard-dose intravenous alteplase for acute ischemic stroke with unknown time of onset
    Wang, Zekun
    Ji, Kangxiang
    Fang, Qi
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [25] Comparison of Effectiveness and Safety of Low- Dose Versus Standard-Dose Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke: A Meta- Analysis
    Karedath, Jithin
    Avanteeka, F. N. U.
    Aslam, Muhammad Nouman
    Nadeem, Ahmad
    Yousaf, Rao Ahmed
    Shah, Sandesh
    Palleti, Sujith K.
    Khan, Areeba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [26] Low-Dose Versus Standard-Dose Tissue Plasminogen Activator for Intravenous Thrombolysis in Asian Acute Ischemic Stroke Patients
    Ng, Kay W. P.
    Sharma, Vijay K.
    STROKE, 2010, 41 (08) : E545 - E546
  • [27] Low-Dose vs. Standard-Dose Intravenous Alteplase in Bridging Therapy Among Patients With Acute Ischemic Stroke: Experience From a Stroke Center in Vietnam
    Mai, Duy Ton
    Dao, Viet Phuong
    Nguyen, Van Chi
    Vu, Dang Luu
    Nguyen, Tien Dung
    Vuong, Xuan Trung
    Bui, Quoc Viet
    Phan, Ha Quan
    Pham, Quang Tho
    Le, Hoang Kien
    Tran, Anh Tuan
    Nguyen, Quang Anh
    Dang, Phuc Duc
    Nguyen, Hoang
    Phan, Hoang Thi
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [28] Effectiveness of Standard-Dose vs. Low-Dose Alteplase for Acute Ischemic Stroke Within 3-4.5 h
    Chen, Chih-Hao
    Tang, Sung-Chun
    Chen, Yu-Wei
    Chen, Chih-Hung
    Tsai, Li-Kai
    Sung, Sheng-Feng
    Lin, Huey-Juan
    Huang, Hung-Yu
    Po, Helen L.
    Sun, Yu
    Chen, Po-Lin
    Chan, Lung
    Wei, Cheng-Yu
    Lee, Jiunn-Tay
    Hsieh, Cheng-Yang
    Lin, Yung-Yang
    Lien, Li-Ming
    Jeng, Jiann-Shing
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [29] Low- versus Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: An Updated Meta-Analysis
    Liu, Huihui
    Zheng, Huaguang
    Cao, Yongjun
    Pan, Yuesong
    Wang, David
    Zhang, Runhua
    You, Shoujiang
    Zhang, Xinmiao
    Li, Shuya
    Tong, Xu
    Liu, Chun-feng
    Wang, Yilong
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (04): : 988 - 997
  • [30] LOW VERSUS STANDARD DOSE INTRAVENOUS ALTEPLASE IN THE TREATMENT OF ACUTE ISCHEMIC STROKE IN EGYPTIAN PATIENTS A COMPARATIVE EFFECTIVENESS AND SAFETY STUDY
    Afifi, K.
    Elsheikh, W.
    El-Shanawany, B.
    Salem, G.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 179 - 179
12345